| AGCLX | CSPAX | AGCLX / CSPAX | |
| Total Expense Ratio | 1.36 | 1.04 | 131% |
| Annual Report Gross Expense Ratio | 1.36 | 1.04 | 131% |
| Fund Existence | 10 years | 24 years | - |
| Gain YTD | 6.266 | 4.763 | 132% |
| Front Load | 6% | 4% | 164% |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 79.7M | 82.4B | 0% |
| Annual Yield % from dividends | 0.45 | 0.67 | 67% |
| Returns for 1 year | 16.24 | 13.19 | 123% |
| Returns for 3 years | 31.51 | 24.19 | 130% |
| Returns for 5 years | -4.61 | -7.69 | 60% |
| Returns for 10 years | N/A | 103.16 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TFPN | 28.29 | 0.24 | +0.86% |
| Blueprint Chesapeake Multi-Asst Trnd ETF | |||
| ISCF | 44.31 | 0.26 | +0.59% |
| iShares MSCI Intl Small-Cap Mltfct ETF | |||
| XBI | 127.65 | 0.30 | +0.24% |
| State Street® SPDR® S&P® Biotech ETF | |||
| GPRF | 50.78 | N/A | N/A |
| Goldman Sachs Acs US Pref Stk &HySecETF | |||
| QRFT | 62.82 | -0.63 | -0.99% |
| QRAFT AI-Enhanced US Large Cap ETF | |||